| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medicine, Division of Endocrinology, Center for the Health Sciences,University of California Los Angeles, California 90024
Institute of Interdisciplinary Research, School of Medicine, Free University of Brussels, Brussels,Belgium; Los Angeles, California 90024
Address all correspondence and requests for reprints to: Dr. J. Unger, Institute of Interdisciplinary Research, School of Medicine, Free University of Brussels, 2, rue Evers, B-1000, Brussels, Belgium.
To elucidate the mechanism of thyroglobulin (Tg) release in man, the effects of an iv injection of a submaximal dose of bovine TSH (bTSH) on the serum levels of Tg were compared with the effects on serum T3.and T4. After the administration of bTSH, short term kinetics (0–4 h) were studied in eight subjects receiving 0.5 IU bTSH and seven subjects receiving 1 IU bTSH. Serum Tg did not significantly increase in either of the short term studies. By contrast, serum T3 increased significantly and linearly after the iv administration of 0.5 and 1 IU bTSH; serum T4 also rose but only after 1 IU bTSH. Long term kinetics (0–120 h) were studied in seven additional subjects after the iv administration of 1 IU bTSH; serum bTSH was no longer detectable after 8 h. Maximum serum concentrations of T3 were obtained at about 4 h, maximum serum concentrations of T4 were obtained between 4-8 h. Serum Tg levels increased linearly with time during the first 24 h. Maximum serum Tg levels correlated well with basal serum Tg values (r = 0.97; P < 0.001). The maximal increment in Tg correlated inversely with the maximal increment in T3 (r = 0.71; P < 0.05). The half-life of Tg was estimated to be approximately 4 days by measuring the disappearance rate of Tg after its peak level was attained.
* This work was supported by the Ministere de la Politique Scientifique,Actions Concertees, and grants from the Association Recherche Biomedicale et Diagnostic (A.R.B.D.) and the NCI (CA-13477).
Received November 20, 1979.
This article has been cited by other articles:
![]() |
L. Ramirez, L. E. Braverman, B. White, and C. H. Emerson Recombinant Human Thyrotropin Is a Potent Stimulator of Thyroid Function in Normal Subjects J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2836 - 2839. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Refetoff and E. G. Lever The Value of Serum Thyroglobulin Measurement in Clinical Practice JAMA, November 4, 1983; 250(17): 2352 - 2357. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |